海外医薬品不足状況

更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。

米国

カナダ

カナダの情報はありません。

オーストラリア

  • 2024.10.29
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    gabapentinCapsule, hard300 mgCurrentLimited AvailabilityManufacturing25/10/2024
    sumatriptan succinateTablet, film coated140 mgCurrentLimited AvailabilityManufacturing25/10/2024
    azithromycin dihydrateTablet, film coated524.1 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply25/10/2024
    dutasteride~tamsulosin hydrochlorideCapsule, modified release500 microgram~400 microgramCurrentLimited AvailabilityManufacturing25/10/2024
    valsartan~hydrochlorothiazideTablet, film coated320 mg~25 mgCurrentLimited AvailabilityManufacturing25/10/2024
    esomeprazole magnesium dihydrateTablet, enteric coated21.75 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues25/10/2024
    clonidine hydrochlorideTablet100 microgramAnticipatedAvailableManufacturing25/10/2024
    fluorouracilInjection, solution50 mg/mLResolvedAvailableManufacturing25/10/2024
    verapamil hydrochlorideTablet, modified release180 mgCurrentLimited AvailabilityManufacturing25/10/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply25/10/2024
    estradiol hemihydrateDrug delivery system, transdermal.77 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply25/10/2024
    oxycodone hydrochlorideCapsule, hard5 mgResolvedAvailableManufacturing25/10/2024
    nizatidineCapsule300 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply25/10/2024
    flecainide acetateInjection, solution10 mg/mLAnticipatedAvailableManufacturing24/10/2024
    topiramateTablet, film coated200 mgAnticipatedAvailableManufacturing24/10/2024
    gliclazideTablet, modified release30 mgResolvedAvailableManufacturing24/10/2024
    donepezil hydrochlorideTablet, film coated5 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues24/10/2024
    bisoprolol fumarateTablet5 mgCurrentUnavailableManufacturing24/10/2024
    bicalutamideTablet, film coated50 mgAnticipatedAvailableManufacturing24/10/2024
    azithromycin dihydrateTablet, film coated524.05 mgCurrentLimited AvailabilityManufacturing24/10/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing24/10/2024
    quetiapine fumarateTablet, film coated28.78 mgAnticipatedAvailableManufacturing24/10/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues24/10/2024
    simvastatinTablet, film coated40 mgCurrentUnavailableManufacturing24/10/2024
    citalopram hydrobromideTablet, film coated49.98 mgCurrentUnavailableManufacturing24/10/2024
    citalopram hydrobromideTablet, film coated49.98 mgAnticipatedAvailableManufacturing24/10/2024
    mitomycinInjection, powder for20 mgResolvedAvailableManufacturing24/10/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply24/10/2024
    emtricitabine~tenofovir disoproxil maleateTablet, film coated200 mg~300 mgCurrentUnavailableManufacturing24/10/2024
    prochlorperazine maleateTablet, uncoated5 mgCurrentUnavailableCommercial Changes / Commercial viability24/10/2024
    nebivolol hydrochlorideTablet1.363 mgCurrentUnavailableManufacturing24/10/2024
    betahistine dihydrochlorideTablet, uncoated16 mgCurrentLimited AvailabilityManufacturing24/10/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentLimited AvailabilityManufacturing24/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing24/10/2024
    azacitidineInjection, powder for100 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability24/10/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentLimited AvailabilityManufacturing24/10/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing24/10/2024
    bortezomibInjection, solution3.5 mgCurrentUnavailableManufacturing24/10/2024
    paracetamolTablet, modified release665 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues24/10/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal4.8 mg~.512 mgCurrentLimited AvailabilityManufacturing24/10/2024
    metformin hydrochlorideTablet, film coated850 mgCurrentUnavailableManufacturing24/10/2024
    pravastatin sodiumTablet, uncoated40 mgCurrentLimited AvailabilityManufacturing24/10/2024
    medronic acidInjection, powder for10 mgCurrentLimited AvailabilityManufacturing23/10/2024
    donepezil hydrochlorideTablet, film coated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues23/10/2024
    levetiracetamTablet, film coated250 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues23/10/2024
    bisoprolol fumarateTablet2.5 mgCurrentUnavailableManufacturing23/10/2024
    bisoprolol fumarateTablet10 mgAnticipatedAvailableManufacturing23/10/2024
    irbesartanTablet, film coated300 mgResolvedAvailableManufacturing23/10/2024
    methotrexateInjection, solution100 mg/mLCurrentUnavailableManufacturing23/10/2024
    epirubicin hydrochlorideInjection, concentrated200 mgCurrentUnavailableManufacturing23/10/2024
    betahistine dihydrochlorideTablet24 mgCurrentLimited AvailabilityUnexpected increase in consumer demand23/10/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableManufacturing23/10/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentUnavailableManufacturing23/10/2024
    tadalafilTablet, film coated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply23/10/2024
    lacosamideTablet, film coated50 mgAnticipatedAvailableManufacturing23/10/2024
    lidocaine hydrochlorideInjection, solution400 mgCurrentUnavailableManufacturing23/10/2024
    amlodipine besilate~olmesartan medoxomil~hydrochlorothiazideTablet, film coated6.95 mg~40 mg~25 mgCurrentUnavailableManufacturing23/10/2024
    amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLResolvedAvailableManufacturing23/10/2024
    cytarabineInjection, solution100 mgCurrentLimited AvailabilityUnexpected increase in consumer demand22/10/2024
    papaverine hydrochlorideInjection, solution12 mg/mLCurrentLimited AvailabilityManufacturing22/10/2024
    clonidine hydrochlorideTablet, uncoated100 microgramResolvedAvailableManufacturing22/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgResolvedAvailableManufacturing22/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.791 mgCurrentLimited AvailabilityManufacturing22/10/2024
    levetiracetamInjection, concentrated500 mgResolvedAvailableManufacturing22/10/2024
    pemetrexed disodiumInjection, powder for1102.9 mgCurrentUnavailableManufacturing22/10/2024
    meloxicamCapsule, hard15 mgAnticipatedAvailableManufacturing22/10/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand22/10/2024
    rasagiline mesilateTablet1.56 mgCurrentLimited AvailabilityManufacturing22/10/2024
    celecoxibCapsule, hard100 mgResolvedAvailableManufacturing22/10/2024
    solifenacin succinateTablet, film coated5 mgCurrentUnavailableManufacturing22/10/2024
    solifenacin succinateTablet, film coated10 mgCurrentUnavailableManufacturing22/10/2024
    lacosamideTablet, film coated100 mgResolvedAvailableManufacturing22/10/2024
    modafinilTablet, uncoated100 mgResolvedAvailableManufacturing22/10/2024
    quinagolide hydrochlorideTablet, uncoated.0819 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability22/10/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand22/10/2024
    norethisterone~ethinylestradiolTablet, uncoated1 mg~36 microgramCurrentLimited AvailabilityManufacturing22/10/2024
    clonidine hydrochlorideTablet, uncoated150 microgramResolvedAvailableManufacturing22/10/2024
    methylphenidate hydrochlorideTablet, modified release54 mgCurrentLimited AvailabilityManufacturing22/10/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.82 mg/mLAnticipatedAvailableManufacturing21/10/2024
    topiramateTablet, film coated25 mgAnticipatedAvailableManufacturing21/10/2024
    pentetic acidInjection, powder for5 mgCurrentLimited AvailabilityManufacturing21/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~10.396 mgCurrentLimited AvailabilityManufacturing21/10/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.791 mg~10 mgCurrentLimited AvailabilityManufacturing21/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentLimited AvailabilityManufacturing21/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~10.396 mgResolvedAvailableManufacturing21/10/2024
    paclitaxelInjection, concentrated300 mgResolvedAvailableManufacturing21/10/2024
    milrinoneInjection, concentrated10 mgResolvedAvailableManufacturing21/10/2024
    cefepime hydrochloride monohydrateInjection, powder for1189.2 mgCurrentLimited AvailabilityManufacturing21/10/2024
    temozolomideCapsule, hard20 mgAnticipatedAvailableManufacturing21/10/2024
    benzatropine mesilateInjection1 mg/mLAnticipatedAvailableManufacturing21/10/2024
    hydromorphone hydrochlorideInjection, solution2 mgCurrentLimited AvailabilityManufacturing21/10/2024
    atorvastatin calcium trihydrateTablet, film coated86.751 mgAnticipatedAvailableManufacturing21/10/2024
    lenalidomideCapsule, hard5 mgResolvedAvailableUnexpected increase in consumer demand21/10/2024
    levothyroxine sodiumTablet50 microgramCurrentUnavailableManufacturing21/10/2024
    clindamycin hydrochlorideSolution10 mg/mLCurrentUnavailableManufacturing21/10/2024
    sodium pertechnetate(99mTc)Injection, solution20 GBqResolvedAvailableManufacturing21/10/2024
    balsalazide sodiumCapsule750 mgResolvedAvailableCommercial Changes / Commercial viability21/10/2024
  • 2024.10.23
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    sumatriptan succinateTablet, film coated140 mgCurrentLimited AvailabilityManufacturing18/10/2024
    topiramateTablet, film coated50 mgAnticipatedAvailableManufacturing18/10/2024
    topiramateTablet, film coated100 mgAnticipatedAvailableManufacturing18/10/2024
    heparin sodiumInjection, solution5000 IU/mLAnticipatedAvailableUnexpected increase in consumer demand18/10/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentLimited AvailabilityManufacturing18/10/2024
    metformin hydrochlorideTablet, modified release1000 mgCurrentLimited AvailabilityManufacturing18/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing18/10/2024
    oxycodone hydrochlorideCapsule, hard10 mgCurrentUnavailableCommercial Changes / Commercial viability18/10/2024
    fenofibrateTablet48 mgResolvedAvailableManufacturing18/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing18/10/2024
    latanoprostEye Drops, solution.05 mg/mLResolvedAvailableTransport / Logistic issues / Storage capacity issues18/10/2024
    lacosamideTablet, film coated150 mgCurrentUnavailableManufacturing18/10/2024
    pregabalinCapsule, hard75 mgResolvedAvailableManufacturing18/10/2024
    pregabalinCapsule, hard75 mgResolvedAvailableManufacturing18/10/2024
    atorvastatin calcium trihydrateTablet, film coated86.751 mgCurrentLimited AvailabilityManufacturing18/10/2024
    trimethoprimTablet, uncoated300 mgCurrentLimited AvailabilityManufacturing18/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing18/10/2024
    indometacinCapsule, hard25 mgCurrentUnavailableManufacturing18/10/2024
    octreotideInjection, solution50 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply18/10/2024
    clonazepamTablet, uncoated.5 mgCurrentLimited AvailabilityManufacturing18/10/2024
    clonazepamTablet, uncoated2 mgCurrentLimited AvailabilityManufacturing18/10/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply18/10/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing18/10/2024
    topiramateTablet, film coated200 mgAnticipatedAvailableManufacturing17/10/2024
    adrenaline (epinephrine)Injection, solution1 mgResolvedAvailableManufacturing17/10/2024
    mitomycinInjection, powder for20 mgCurrentUnavailableManufacturing17/10/2024
    azacitidineInjection, powder for100 mgCurrentUnavailableManufacturing17/10/2024
    irbesartanTablet, film coated150 mgResolvedAvailableManufacturing17/10/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing17/10/2024
    lisdexamfetamine dimesilateCapsule, hard60 mgResolvedAvailableUnexpected increase in consumer demand17/10/2024
    letrozoleTablet, film coated2.5 mgCurrentLimited AvailabilityManufacturing17/10/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing17/10/2024
    daptomycinInjection, powder for500 mgCurrentUnavailableCommercial Changes / Commercial viability17/10/2024
    tamoxifen citrateTablet30.34 mgCurrentLimited AvailabilityManufacturing17/10/2024
    olanzapine pamoate monohydrateInjection, powder for931 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues16/10/2024
    risperidoneTablet, film coated4 mgAnticipatedAvailableManufacturing16/10/2024
    rocuronium bromideInjection, solution50 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/10/2024
    adrenaline (epinephrine)Injection, solution1 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, multilayer10.9 mg~10 mgResolvedAvailableManufacturing16/10/2024
    entecavirTablet, film coated1 mgResolvedAvailableManufacturing16/10/2024
    hydrochlorothiazide~irbesartanTablet, film coated25 mg~300 mgAnticipatedAvailableManufacturing16/10/2024
    tadalafilTablet, film coated10 mgAnticipatedAvailableManufacturing16/10/2024
    tadalafilTablet, film coated5 mgResolvedAvailableManufacturing16/10/2024
    cisplatinInjection, concentrated1 mg/mLAnticipatedAvailableManufacturing16/10/2024
    linezolidTablet, film coated600 mgResolvedAvailableUnexpected increase in consumer demand16/10/2024
    latanoprost~timolol maleateEye Drops, solution.05 mg/mL~6.83 mg/mLAnticipatedAvailableManufacturing16/10/2024
    dutasteride~tamsulosin hydrochlorideCapsule, modified release500 microgram~400 microgramAnticipatedAvailableTransport / Logistic issues / Storage capacity issues16/10/2024
    bendamustine hydrochloride monohydrateInjection, powder for100 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2024
    amlodipine besilate~olmesartan medoxomilTablet, film coated6.94 mg~40 mgCurrentUnavailableUnexpected increase in consumer demand16/10/2024
    methylphenidate hydrochlorideTablet, modified release27 mgResolvedAvailableManufacturing16/10/2024
    daptomycinInhalation, powder for350 mgAnticipatedAvailableManufacturing16/10/2024
    enoxaparin sodiumInjection, solution20 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~41.6 mgCurrentUnavailableManufacturing16/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.8 mgResolvedAvailableManufacturing16/10/2024
    nizatidineCapsule, hard300 mgResolvedAvailableManufacturing16/10/2024
    TenecteplaseInjection, powder for50 mgResolvedAvailableUnexpected increase in consumer demand16/10/2024
    sodium pertechnetate(99mTc)Injection370 GBqResolvedAvailableManufacturing16/10/2024
    ciprofloxacin hydrochlorideTablet, film coated873.32 mgAnticipatedAvailableManufacturing16/10/2024
    nizatidineCapsule150 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply16/10/2024
    nizatidineCapsule, hard300 mgResolvedAvailableManufacturing16/10/2024
    acetylcholine chlorideSolution, powder for irrigation10 mg/mLCurrentUnavailableManufacturing15/10/2024
    daunorubicinInjection, solution20 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability15/10/2024
    anidulafunginInjection, powder for100 mgCurrentLimited AvailabilityManufacturing15/10/2024
    mycophenolate mofetilTablet, film coated500 mgCurrentLimited AvailabilityManufacturing15/10/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing15/10/2024
    Digoxinspecific antibody fragment F(ab) (Ovine)Injection, powder for40 mgAnticipatedAvailableManufacturing15/10/2024
    duloxetine hydrochlorideCapsule, enteric33.66 mgCurrentUnavailableUnexpected increase in consumer demand15/10/2024
    escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues15/10/2024
    escitalopram oxalateTablet, film coated25.47 mgCurrentUnavailableManufacturing15/10/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues15/10/2024
    Follitropin alfaInjection, solution75 IUCurrentLimited AvailabilityManufacturing15/10/2024
    atorvastatin calcium trihydrateTablet, film coated86.76 mgResolvedAvailableManufacturing15/10/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentLimited AvailabilityManufacturing15/10/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply15/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityUnexpected increase in consumer demand15/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing15/10/2024
    prasugrelTablet, film coated5 mgCurrentUnavailableManufacturing15/10/2024
    prasugrelTablet, film coated10 mgCurrentLimited AvailabilityManufacturing15/10/2024
    estradiolDrug delivery system, transdermal.585 mgCurrentUnavailableManufacturing15/10/2024
    estradiolDrug delivery system, transdermal1.17 mgCurrentUnavailableManufacturing15/10/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing15/10/2024
    pegcetacoplanInjection, solution1080 mgResolvedAvailableManufacturing15/10/2024
    rocuronium bromideInjection, solution10 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability15/10/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~2.7 mgResolvedAvailableManufacturing15/10/2024
    pimecrolimusCream10 mg/gResolvedAvailableManufacturing15/10/2024
    clarithromycinTablet, film coated250 mgAnticipatedAvailableUnexpected increase in consumer demand15/10/2024
    griseofulvinTablet, uncoated125 mgResolvedAvailableManufacturing14/10/2024
    olsalazine sodiumCapsule250 mgCurrentUnavailableManufacturing14/10/2024
    iopromideInjection, solution498.72 mg/mLCurrentUnavailableUnexpected increase in consumer demand14/10/2024
    telmisartan~hydrochlorothiazideTablet, film coated80 mg~12.5 mgCurrentLimited AvailabilityManufacturing14/10/2024
    esomeprazole magnesium dihydrateTablet, enteric coated21.75 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues14/10/2024
    benzathine benzylpenicillin tetrahydrateInjection, suspension600000 USP UnitCurrentUnavailableManufacturing14/10/2024
    oseltamivir phosphateCapsule, hard98.524 mgAnticipatedAvailableUnexpected increase in consumer demand14/10/2024
    thiotepaInjection, powder for15 mgAnticipatedAvailableCommercial Changes / Commercial viability14/10/2024
    betahistine dihydrochlorideTablet16 mgResolvedAvailableUnexpected increase in consumer demand14/10/2024
    cisplatinInjection, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply14/10/2024
    olsalazine sodiumTablet, uncoated500 mgCurrentUnavailableManufacturing14/10/2024
    clarithromycinTablet, film coated250 mgCurrentLimited AvailabilityManufacturing11/10/2024
    primidoneTablet, uncoated250 mgCurrentLimited AvailabilityManufacturing11/10/2024
    neostigmine methylsulfateInjection, solution2.5 mgAnticipatedAvailableManufacturing11/10/2024
    tadalafilTablet5 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply11/10/2024
    tadalafilTablet, film coated5 mgResolvedAvailableManufacturing11/10/2024
    heparin sodiumInjection, solution5000 IU/mLCurrentLimited AvailabilityManufacturing11/10/2024
    midazolamInjection, solution5 mg/mLResolvedAvailableManufacturing11/10/2024
    metoprolol succinateTablet, modified release190 mgAnticipatedAvailableManufacturing10/10/2024
    bisoprolol fumarateTablet5 mgCurrentUnavailableManufacturing10/10/2024
    nebivolol hydrochlorideTablet1.363 mgAnticipatedAvailableManufacturing10/10/2024
  • 2024.10.10
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    atropine sulfate monohydrateInjection, solution1.2 mg/mLResolvedAvailableManufacturing9/10/2024
    acetylcysteineInjection, concentrated2 gAnticipatedAvailableManufacturing9/10/2024
    trandolaprilCapsule2 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues9/10/2024
    isosorbide dinitrateTablet, uncoated5 mgCurrentLimited AvailabilityManufacturing9/10/2024
    morphine hydrochloride trihydrateOral Liquid, solution1 mg/mLResolvedAvailableCommercial Changes / Commercial viability9/10/2024
    risperidoneTablet, film coated1 mgCurrentUnavailableManufacturing9/10/2024
    acetylcysteineInjection, concentrated2 gCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues9/10/2024
    galantamine hydrobromideCapsule, modified release30.756 mgAnticipatedAvailableManufacturing9/10/2024
    adrenaline (epinephrine) acid tartrateInjection, solution182 microgram/mLCurrentUnavailableManufacturing9/10/2024
    citalopram hydrobromideTablet, film coated49.98 mgAnticipatedAvailableManufacturing9/10/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableManufacturing9/10/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues9/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing9/10/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply9/10/2024
    metformin hydrochlorideTablet, film coated850 mgResolvedAvailableManufacturing9/10/2024
    lacosamideTablet, film coated100 mgResolvedAvailableManufacturing9/10/2024
    codeine phosphate hemihydrate~doxylamine succinate~paracetamolTablet, uncoated30 mg~5 mg~450 mgResolvedAvailableManufacturing9/10/2024
    amlodipine besilate~hydrochlorothiazide~olmesartan medoxomilTablet, film coated6.95 mg~12.5 mg~40 mgCurrentUnavailableManufacturing9/10/2024
    calcium chloride dihydrate~magnesium chloride hexahydrate~sodium lactate~glucose~sodium chlorideSolution, irrigation183 mg/L~50.8 mg/L~4.48 g/L~15 g/L~5.38 g/LCurrentLimited AvailabilityManufacturing8/10/2024
    calcium chloride dihydrate~glucose~sodium lactate~magnesium chloride hexahydrate~sodium chlorideSolution, irrigation183 mg/L~25 g/L~4.48 g/L~50.8 mg/L~5.38 g/LCurrentLimited AvailabilityManufacturing8/10/2024
    levetiracetamTablet, film coated500 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues8/10/2024
    codeine phosphate hemihydrate~doxylamine succinate~paracetamolTablet, uncoated10 mg~5.1 mg~500 mgCurrentUnavailableManufacturing8/10/2024
    paclitaxelInjection, concentrated300 mgCurrentUnavailableManufacturing8/10/2024
    milrinoneInjection, concentrated10 mgCurrentLimited AvailabilityManufacturing8/10/2024
    azithromycin dihydrateTablet, film coated524 mgCurrentUnavailableManufacturing8/10/2024
    cisplatinInjection, concentrated1 mg/mLAnticipatedAvailableManufacturing8/10/2024
    lacosamideTablet, film coated150 mgCurrentUnavailableManufacturing8/10/2024
    gliclazideTablet, uncoated80 mgResolvedAvailableUnexpected increase in consumer demand8/10/2024
    ketorolac trometamolInjection, solution30 mg/mLResolvedAvailableManufacturing8/10/2024
    phentermine hydrochlorideTablet, modified release49.7 mgCurrentLimited AvailabilityManufacturing8/10/2024
    carmustineInjection, powder for100 mgCurrentUnavailableManufacturing8/10/2024
    methotrexateTablet10 mgCurrentLimited AvailabilityManufacturing8/10/2024
    sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrentUnavailableManufacturing8/10/2024
    sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrentUnavailableManufacturing8/10/2024
    sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing8/10/2024
    AdalimumabInjection, solution40 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability8/10/2024
    levothyroxine sodiumTablet, uncoated.05 mgCurrentUnavailableManufacturing8/10/2024
    cisplatinInjection, solution1 mg/mLResolvedAvailableUnexpected increase in consumer demand8/10/2024
    verapamil hydrochlorideTablet, modified release180 mgCurrentLimited AvailabilityManufacturing8/10/2024
    rifabutinCapsule, hard150 mgResolvedAvailableManufacturing8/10/2024
    rizatriptan benzoateWafer14.53 mgResolvedAvailableManufacturing8/10/2024
    pamidronate disodiumInjection, concentrated6 mgCurrentLimited AvailabilityManufacturing8/10/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLResolvedAvailableManufacturing8/10/2024
    pegcetacoplanInjection, solution1080 mgAnticipatedAvailableManufacturing7/10/2024
    duloxetine hydrochlorideCapsule, enteric33.7 mgDiscontinuedUnavailableCommercial Changes / Commercial viability4/10/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgDiscontinuedUnavailableCommercial Changes / Commercial viability4/10/2024
    medronic acidInjection, powder for10 mgAnticipatedAvailableManufacturing4/10/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgDiscontinuedUnavailableCommercial Changes / Commercial viability4/10/2024
    LiraglutideInjection, solution6 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability4/10/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply4/10/2024
    Choriogonadotropin alfaInjection, solution250 microgramCurrentEmergency Supply OnlyUnexpected increase in consumer demand4/10/2024
    noradrenaline (norepinephrine) acid tartrate monohydrateInjection, concentrated8 mgCurrentLimited AvailabilityManufacturing4/10/2024
    topotecan hydrochlorideInjection, concentrated4.346 mgCurrentUnavailableManufacturing4/10/2024
    Rabies virusPowder3.25 IUResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply4/10/2024
    sumatriptan succinateTablet, film coated140 mgCurrentLimited AvailabilityManufacturing3/10/2024
    midazolamInjection, solution5 mgCurrentLimited AvailabilityManufacturing3/10/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentLimited AvailabilityManufacturing3/10/2024
    clonidine hydrochlorideTablet, uncoated100 microgramCurrentLimited AvailabilityManufacturing3/10/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing3/10/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentUnavailableManufacturing3/10/2024
    telmisartan~hydrochlorothiazideTablet, film coated80 mg~12.5 mgCurrentLimited AvailabilityManufacturing3/10/2024
    quetiapine fumarateTablet, film coated28.78 mgCurrentLimited AvailabilityManufacturing3/10/2024
    metformin hydrochlorideTablet, modified release1000 mgCurrentLimited AvailabilityManufacturing3/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing3/10/2024
    betahistine dihydrochlorideTablet16 mgResolvedAvailableManufacturing3/10/2024
    potassium clavulanate~amoxicillin trihydrateTablet, film coated148.875 mg~1006.25 mgResolvedAvailableManufacturing3/10/2024
    clonidine hydrochlorideTablet100 microgramResolvedAvailableUnexpected increase in consumer demand3/10/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentUnavailableManufacturing3/10/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentLimited AvailabilityManufacturing3/10/2024
    celecoxibCapsule, hard100 mgCurrentLimited AvailabilityManufacturing3/10/2024
    apomorphine hydrochloride hemihydrateInjection, solution10 mgCurrentLimited AvailabilityManufacturing3/10/2024
    lacosamideTablet, film coated100 mgCurrentUnavailableManufacturing3/10/2024
    eftrenonacog alfaInjection, powder for4000 IUResolvedAvailableManufacturing3/10/2024
    atorvastatin calcium trihydrateTablet, film coated86.751 mgAnticipatedAvailableManufacturing3/10/2024
    trimethoprimTablet, uncoated300 mgAnticipatedAvailableManufacturing3/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing3/10/2024
    indometacinCapsule, hard25 mgCurrentUnavailableManufacturing3/10/2024
    mycophenolate mofetilSuspension200 mg/mLResolvedAvailableManufacturing3/10/2024
    levothyroxine sodiumTablet, uncoated.075 mgCurrentUnavailableManufacturing3/10/2024
    levothyroxine sodiumTablet, uncoated.2 mgCurrentUnavailableManufacturing3/10/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply3/10/2024
    imipramine hydrochlorideTablet, sugar coated25 mgCurrentUnavailableManufacturing3/10/2024
    estradiol hemihydrateDrug delivery system, transdermal.77 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply3/10/2024
    estradiol hemihydrateDrug delivery system, transdermal3.09 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply3/10/2024
    celecoxibCapsule, hard100 mgResolvedAvailableManufacturing3/10/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgCurrentUnavailableManufacturing3/10/2024
    amoxicillin trihydrateTablet, film coated1148 mgResolvedAvailableManufacturing3/10/2024
    ciprofloxacin hydrochlorideTablet, film coated873.32 mgAnticipatedAvailableManufacturing3/10/2024
    nizatidineCapsule150 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply3/10/2024
    lisinopril dihydrateTablet, uncoated10.89 mgResolvedAvailableManufacturing2/10/2024
    escitalopram oxalateTablet, film coated25.56 mgResolvedAvailableManufacturing2/10/2024
    topiramateTablet, film coated200 mgAnticipatedAvailableManufacturing2/10/2024
    zolpidem tartrateTablet, film coated10 mgAnticipatedAvailableManufacturing2/10/2024
    isoniazidTablet, uncoated100 mgResolvedAvailableManufacturing2/10/2024
    ciprofloxacin hydrochlorideTablet, film coated832.5 mgAnticipatedAvailableManufacturing2/10/2024
    gliclazideTablet, modified release30 mgAnticipatedAvailableManufacturing2/10/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing2/10/2024
    silver sulfadiazineCream10 mg/gCurrentLimited AvailabilityManufacturing2/10/2024
    risperidoneTablet, film coated4 mgAnticipatedAvailableManufacturing2/10/2024
    donepezil hydrochlorideTablet, film coated5 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues2/10/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgCurrentLimited AvailabilityManufacturing2/10/2024
    bicalutamideTablet, film coated50 mgAnticipatedAvailableManufacturing2/10/2024
    quetiapine fumarateTablet, film coated115.12 mgResolvedAvailableManufacturing2/10/2024
    quetiapine fumarateTablet, film coated345.36 mgCurrentLimited AvailabilityManufacturing2/10/2024
    simvastatinTablet, film coated80 mgAnticipatedAvailableManufacturing2/10/2024
    citalopram hydrobromideTablet, film coated49.98 mgAnticipatedAvailableManufacturing2/10/2024
    fluorouracilInjection, solution50 mg/mLCurrentLimited AvailabilityManufacturing2/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing2/10/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgCurrentUnavailableManufacturing2/10/2024
    fluconazoleCapsule, hard200 mgAnticipatedAvailableManufacturing2/10/2024
    phenytoin sodiumCapsule, hard100 mgResolvedAvailableManufacturing2/10/2024
    lacosamideTablet, film coated50 mgAnticipatedAvailableManufacturing2/10/2024
    risperidoneOral Liquid, solution1 mg/mLResolvedAvailableManufacturing2/10/2024
    teriflunomideTablet, film coated14 mgAnticipatedAvailableManufacturing2/10/2024
    pregabalinCapsule, hard75 mgAnticipatedAvailableManufacturing2/10/2024
    pregabalinCapsule, hard75 mgAnticipatedAvailableManufacturing2/10/2024
    methylphenidate hydrochlorideTablet, modified release54 mgCurrentUnavailableManufacturing2/10/2024
    captoprilTablet, uncoated25 mgResolvedAvailableManufacturing2/10/2024
    captoprilTablet, uncoated50 mgResolvedAvailableManufacturing2/10/2024
    indapamide hemihydrateTablet2.5 mgResolvedAvailableManufacturing2/10/2024
    metformin hydrochlorideTablet, film coated1000 mgResolvedAvailableManufacturing2/10/2024
    rasagiline mesilateTablet1.56 mgCurrentLimited AvailabilityManufacturing1/10/2024
    Rabies virusInjection, powder for2.5 IUResolvedAvailableManufacturing1/10/2024
    prasugrelTablet, film coated10 mgCurrentLimited AvailabilityManufacturing1/10/2024
    spironolactoneTablet, uncoated100 mgResolvedAvailableManufacturing1/10/2024
    sugammadex sodiumInjection, solution217.6 mgResolvedAvailableCommercial Changes / Commercial viability1/10/2024
    Follitropin betaInjection, solution833 IU/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability1/10/2024
    clonidine hydrochlorideTablet, uncoated150 microgramCurrentLimited AvailabilityManufacturing1/10/2024
    Peginterferon alfa2aInjection, solution135 microgramAnticipatedAvailableUnexpected increase in consumer demand1/10/2024
    Peginterferon alfa2aInjection, solution180 microgramAnticipatedAvailableUnexpected increase in consumer demand1/10/2024
    pimecrolimusCream10 mg/gCurrentLimited AvailabilityManufacturing1/10/2024
    griseofulvinTablet, uncoated125 mgCurrentUnavailableManufacturing30/09/2024
    sodium pyrophosphateInjection, powder for30 mgCurrentLimited AvailabilityManufacturing30/09/2024
    hydrocortisone sodium succinateInjection, powder for134 mgResolvedAvailableManufacturing30/09/2024
    cefepime hydrochloride monohydrateInjection, powder for1189.2 mgAnticipatedAvailableManufacturing30/09/2024
    lacosamideTablet, film coated100 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/09/2024
    lacosamideTablet, film coated150 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues30/09/2024
    heparin sodiumInjection, solution5000 IU/mLCurrentLimited AvailabilityManufacturing30/09/2024

ドイツ

  • 2024.10.29
    Active ingredientsDate of the last messageType of reasonMessage type
    Salbutamol sulfate25.10.2024OtherInitial notification
    Samarium-((153)Sm)-Lexidronam pentasodium25.10.2024Production problemInitial notification
    Tobramycin25.10.2024OtherChange notification
    Betamethasone25.10.2024OtherInitial notification
    Metoprolol succinate (Ph.Eur.)25.10.2024OtherChange notification
    Phenoxymethylpenicillin potassium25.10.2024OtherChange notification
    Ciprofloxacin hydrochloride (1:1) 1 H<2>O25.10.2024OtherChange notification
    Amoxicillin trihydrate25.10.2024OtherChange notification
    Fluticasone propionate (Ph.Eur.)25.10.2024OtherInitial notification
    Cefaclor monohydrate24.10.2024OtherChange notification
    Clarithromycin24.10.2024OtherChange notification
    Phenoxymethylpenicillin potassium24.10.2024OtherChange notification
    Oxcarbazepine24.10.2024OtherChange notification
    Paricalcitol24.10.2024OtherChange notification
    Tacrolimus monohydrate24.10.2024OtherChange notification
    Doxycycline hyclate24.10.2024OtherChange notification
    Amoxicillin trihydrate24.10.2024OtherChange notification
    Phenoxymethylpenicillin potassium24.10.2024OtherChange notification
    Sodium (methylprednisolone-21-succinate)23.10.2024OtherInitial notification
    Clonazepam23.10.2024OtherInitial notification
    Levetiracetam23.10.2024OtherChange notification
    Ciprofloxacin lactate23.10.2024OtherChange notification
    Timolol maleate23.10.2024Production problemChange notification
    Proxymetacaine hydrochloride23.10.2024Production problemChange notification
    Atropine sulphate (Ph.Eur.)23.10.2024Production problemChange notification
    Fluorometholone23.10.2024Production problemChange notification
    ofloxacin23.10.2024Production problemChange notification
    Hydrocortisone acetate (Ph.Eur.)23.10.2024Production problemChange notification
    Dexamethasone; gentamicin sulphate23.10.2024Production problemChange notification
    Anidulafungin22.10.2024Production problemInitial notification
    Sodium((99)Mo)molybdate; sodium((99m)Tc)pertechnetate22.10.2024Production problemInitial notification
    Buprenorphine22.10.2024OtherChange notification
    Hydromorphone hydrochloride22.10.2024OtherChange notification
    Buprenorphine22.10.2024OtherChange notification
    [(186)Re]Rhenium sulfide o.w.A.21.10.2024Production problemInitial notification
    ((169)Er)Erbium citrate21.10.2024Production problemInitial notification
    ((90)Y)Yttrium citrate21.10.2024Production problemInitial notification
    Morphine sulphate (Ph.Eur.)21.10.2024Production problemChange notification
    Buprenorphine hydrochloride21.10.2024Production problemInitial notification
    Olanzapine embonate monohydrate21.10.2024Production problemChange notification
    Hydrocortisone21.10.2024OtherInitial notification
    Fluorouracil21.10.2024OtherChange notification
    Flunisolide hemihydrate21.10.2024OtherInitial notification
    Tobramycin21.10.2024OtherChange notification
  • 2024.10.23
    Active ingredientsMessage typeType of reasonDate of the last message
    Venlafaxine hydrochlorideChange notificationProduction problem18.10.2024
    Venlafaxine hydrochlorideInitial notificationProduction problem18.10.2024
    Venlafaxine hydrochlorideInitial notificationProduction problem18.10.2024
    LevetiracetamChange notificationOther18.10.2024
    Hydromorphone hydrochlorideChange notificationOther18.10.2024
    LinezolidInitial notificationOther17.10.2024
    CiclosporinInitial notificationOther17.10.2024
    Azithromycin dihydrateChange notificationOther17.10.2024
    Azithromycin dihydrateChange notificationOther17.10.2024
    Amoxicillin trihydrateInitial notificationOther17.10.2024
    Amoxicillin trihydrate; potassium clavulanateInitial notificationOther17.10.2024
    EverolimusInitial notificationOther16.10.2024
    OxcarbazepineInitial notificationOther16.10.2024
    Urea; tretinoinChange notificationOther16.10.2024
    Azithromycin monohydrateChange notificationOther16.10.2024
    Phenoxymethylpenicillin potassiumChange notificationOther16.10.2024
    PhenobarbitalChange notificationOther16.10.2024
    HaloperidolInitial notificationOther16.10.2024
    EthosuximideChange notificationOther16.10.2024
    Amoxicillin trihydrateChange notificationOther16.10.2024
    Minocycline hydrochloride ((anhydrous, not pharmacopoeia compliant))Change notificationOther16.10.2024
    Solifenacin succinateInitial notificationProduction problem15.10.2024
    Eletriptan hydrobromideChange notificationOther15.10.2024
    LevetiracetamChange notificationProduction problem14.10.2024
    Insulin aspartChange notificationOther14.10.2024
    Insulin aspartChange notificationOther14.10.2024
    Remifentanil hydrochlorideChange notificationOther14.10.2024
    Oxycodone hydrochloride (Ph.Eur.)Initial notificationOther14.10.2024
    Pramipexole dihydrochloride monohydrateInitial notificationOther14.10.2024
    Pramipexole dihydrochloride monohydrateChange notificationOther14.10.2024
    Pramipexole dihydrochloride monohydrateChange notificationOther14.10.2024
    EtoricoxibInitial notificationOther14.10.2024
    Eletriptan hydrobromideInitial notificationOther14.10.2024
    Oxycodone hydrochloride (Ph.Eur.)Change notificationOther14.10.2024
    TopiramateChange notificationOther14.10.2024
    Lanthanum(III) carbonate x H<2>OInitial notificationOther14.10.2024
    OmeprazoleChange notificationOther14.10.2024
    PhenytoinInitial notificationOther14.10.2024
    Ciprofloxacin hydrochloride (1:1) 1 H<2>OChange notificationOther14.10.2024
    ParicalcitolChange notificationOther14.10.2024
    OxcarbazepineChange notificationOther14.10.2024
    Phenoxymethylpenicillin potassiumChange notificationOther14.10.2024
    Phenoxymethylpenicillin potassiumChange notificationOther14.10.2024
    Phenoxymethylpenicillin benzathineInitial notificationOther14.10.2024
    ItraconazoleChange notificationOther14.10.2024
    Hydromorphone hydrochlorideChange notificationOther14.10.2024
    UrapidilChange notificationOther11.10.2024
    Amoxicillin trihydrateChange notificationOther11.10.2024
    Hydrochlorothiazide; metoprolol tartrate (Ph.Eur.)Change notificationOther11.10.2024
    Sodium hydrogen carbonateChange notificationOther11.10.2024
    Methylphenidate hydrochlorideChange notificationOther11.10.2024
    Methylphenidate hydrochlorideChange notificationOther11.10.2024
    Methylphenidate hydrochlorideChange notificationOther11.10.2024
    Methylphenidate hydrochlorideChange notificationOther11.10.2024
    Turoctocog alfaInitial notificationOther10.10.2024
    Eptacog alfa (activated)Initial notificationOther10.10.2024
    PhenprocoumonChange notificationProduction problem10.10.2024
    Estradiol hemihydrateInitial notificationProduction problem10.10.2024
    Tenofovir disoproxilChange notificationOther10.10.2024
    Rasagiline mesilateChange notificationProduction problem10.10.2024
    Salbutamol sulfateChange notificationOther10.10.2024
    Amoxicillin trihydrateChange notificationOther10.10.2024
    Ciprofloxacin hydrochloride (1:1) 1 H<2>OChange notificationOther10.10.2024
    Metoprolol tartrate (Ph.Eur.)Change notificationOther10.10.2024
  • 2024.10.10
    有効成分投与形態理由メッセージの種類最後のメッセージの日付
    オランザピンエンボン酸一水和物Erhte 需要変更通知09.10.2024
    オランザピンエンボン酸一水和物パウダーメーカー変更変更通知09.10.2024
    インスリンアスパルトInjektionslungその他変更通知09.10.2024
    ベタメタゾン酢酸エステル(Ph.Eur.);ベタメタゾンリン酸二水素二ナトリウム(Ph.Eur.)インジェクション・サスペンション生産能力不足最初の通知09.10.2024
    アジスロマイシン一水和物フィルムコート錠Erhte 需要変更通知09.10.2024
    コレカルシフェロール経口ドロップ生産能力不足最初の通知09.10.2024
    クエン酸スフェンタニルInjektionslung生産における問題最初の通知08.10.2024
    エゼチミブタブレットErhte 需要変更通知08.10.2024
    エプタコグ アルファ(活性化)パウダー生産能力不足最初の通知08.10.2024
    アモキシシリン三水和物経口懸濁液調製用粉末Erhte 需要変更通知08.10.2024
    セマグルチドInjektionslungErhte 需要変更通知08.10.2024
    フマル酸クエチアピン(欧州製薬)徐放錠生産における問題最初の通知07.10.2024
    オメプラゾール腸溶性コーティング・ハードカプセルErhte 需要変更通知07.10.2024
    トブラマイシン注射用LungErhte 需要最初の通知07.10.2024
    フェノキシメチルペニシリンカリウム経口用 Lung 調製用粉末Erhte 需要変更通知07.10.2024
    フマル酸クエチアピン(欧州製薬)徐放錠生産における問題変更通知07.10.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知07.10.2024
    リザトリプタン安息香酸塩タブレット生産における問題変更通知07.10.2024
    リザトリプタン安息香酸塩溶解タブレット生産における問題変更通知07.10.2024
    リザトリプタン安息香酸塩タブレット生産における問題変更通知07.10.2024
    リネゾリドフィルムコート錠Erhte 需要変更通知07.10.2024
    エゼチミブタブレットErhte 需要変更通知07.10.2024
    エゼチミブ; シンバスタチンタブレットバッチテストの問題点変更通知07.10.2024
    ヒドロモルフォン塩酸塩ハードカプセル生産能力不足最初の通知07.10.2024
    塩酸ベナゼプリル変更通知07.10.2024
    <2>シトロネン舫-レ-ビスマス-カリウム塩(2:1:5)×H O; メトロニダゾール; 塩酸テトラサイクリンハードカプセルErhte 需要変更通知04.10.2024
    塩酸レミフェンタニル粉末・・・注射剤/輸液用濃縮液ungErhte 需要変更通知04.10.2024
    トラゾドン塩酸塩タブレット生産能力不足変更通知04.10.2024
    フェノキシメチルペニシリンカリウムフィルムコート錠その他変更通知04.10.2024
    オクスカルバゼピン経口懸濁液その他変更通知04.10.2024
    クラリスロマイシン経口懸濁液調製用顆粒Erhte 需要変更通知04.10.2024
    アジスロマイシン二水和物経口懸濁液調製用粉末Erhte 需要変更通知04.10.2024
    ラモトリギンタブレット生産能力不足変更通知04.10.2024
    パリカルシトールInjektionslungErhte 需要変更通知04.10.2024
    ジヒドロコデイン[(R変更通知03.10.2024
    ウロキナーゼ注射剤/輸液用粉末ungErhte 需要変更通知02.10.2024
    オランザピンエンボン酸一水和物パウダーメーカー変更最初の通知02.10.2024
    エトスクシミドソフトカプセルErhte 需要変更通知02.10.2024
    硫酸フラマイセチン(1:x) ((硫黄含有量の詳細))肌に塗布するパウダー生産能力不足変更通知02.10.2024
    フシジン(Ph.Eur.)クリーム生産能力不足変更通知02.10.2024
    ドキシサイクリン一水和物タブレット生産能力不足最初の通知02.10.2024
    モメタゾンフロエート(Ph.Eur.)L、皮膚に塗布する。生産能力不足変更通知01.10.2024
    プレドニカルベートL、皮膚に塗布する。生産能力不足最初の通知01.10.2024
    タクロリムス一水和物軟膏Erhte 需要変更通知01.10.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要変更通知01.10.2024
    酢酸プレドニゾロン点眼液懸濁液生産における問題変更通知01.10.2024
    カスポファンギンジアセテート01.10.2024最初の通知01.10.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知01.10.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知01.10.2024
    クラリスロマイシン経口懸濁液調製用顆粒Erhte 需要変更通知30.09.2024
    塩酸バンコマイシンハードカプセルErhte 需要変更通知30.09.2024
    塩酸シナカルセスフィルムコート錠生産における問題最初の通知30.09.2024
    ヒドロモルフォン塩酸塩徐放錠生産における問題変更通知30.09.2024
    ニクロサミドチュアブル錠その他最初の通知30.09.2024
    塩酸レミフェンタニル粉末・・・注射剤/輸液用濃縮液ungErhte 需要変更通知27.09.2024
    アモキシシリン三水和物経口懸濁液調製用粉末Erhte 需要変更通知27.09.2024
    エプタコグ アルファ(活性化)パウダー生産能力不足最初の通知27.09.2024
    硫酸ビンクリスチンInjektionslung生産における問題最初の通知27.09.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知26.09.2024
    メトロニダゾールタブレット生産における問題変更通知26.09.2024
    クラリスロマイシンフィルムコート錠生産能力不足最初の通知26.09.2024
    ノナコグ・ベータ・ペゴルパウダー生産能力不足最初の通知26.09.2024
    塩酸シナカルセスその他変更通知25.09.2024
    リスペリドンデポー注射用懸濁液調製用粉末Erhte 需要最初の通知25.09.2024
    チモロールマレイン酸塩目薬生産における問題変更通知25.09.2024
    クロモグリク酸ナトリウム(Ph.Eur.);塩酸レプロテロール生産における問題変更通知25.09.2024
    タクロリムス一水和物生産における問題変更通知25.09.2024
    塩酸メチルフェニデートタブレットその他変更通知24.09.2024
    フェノキシメチルペニシリンカリウムタブレットErhte 需要最初の通知24.09.2024
    ドキシサイクリン塩酸塩タブレットErhte 需要最初の通知24.09.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠Erhte 需要変更通知23.09.2024
    硫酸サルブタモールLung f・ネブライザー生産能力不足最初の通知23.09.2024
    ラモトリギンタブレット生産における問題最初の通知23.09.2024
    レベチラセタムフィルムコート錠生産における問題変更通知23.09.2024

フランス

  • 2024.10.29
    StatusUpdateSpecialty
    Supply tensionOct. 25, 2024Cynomel 0.025 mg, scored tablet- [liothyronine sodium]
    Supply tensionOct. 25, 2024Ultratechnekow FM, 2.15 – 43 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de)
    Supply voltageOct. 25, 2024Tekcis 2-50 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de)
    Marketing discontinuedOct. 25, 2024Heparin Choay 25 000 IU/5 ml, solution for injection, 1 glass vial(s) of 5 ml – [heparin sodium].
    Marketing discontinuationOct. 24, 2024Tsoludose, oral solution in unidose container – [levothyroxine]
    Supply tension24-Oct-24Clarithromycin 25 mg/ml and 50 mg/ml, granules for oral suspension – [clarithromycin]
    Supply tensionOct. 24, 2024Clarithromycin, 250 and 500 mg, modified-release film-coated tablet and film-coated tablet – [clarithromycin]
    Supply tensionOct. 23, 2024Amikacine Viatris 250 mg, 500 mg and 1g, powder for injectable solution in vial – [amikacine (sulfate d’)
    AvailabilityOct. 23, 2024Hospira sodium pamidronate 9 mg/ml, dilutable solution for infusion – [sodium (pamidronate de)]
    AvailabilityOct. 23, 2024Ultiva 1 mg, powder for solution for injection or infusion – [remifentanil (hydrochloride)]
    Supply tensionOct. 22, 2024Zypadhera 210, 300, 405 mg, powder and solvent for prolonged-release suspension for injection – [olanzapine (pamoate) monohydrate].
    Supply tensionOct. 22, 2024Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringes – [peginterferon alfa-2a] [peginterferon alfa-2a] [peginterferon alfa-2a] [peginterferon alfa-2a
    Out of stockOct. 21, 2024Icatibant Viatris 30 mg, solution for injection in pre-filled syringe – [icatibant (acetate)
    Supply tensionOct. 21, 2024Hexatrione 2 per cent, suspension for injection (intra-articular) – [Triamcinolone Hexacetonide].
  • 2024.10.23
    StatusUpdateSpecialty
    Out of stockOct. 18, 2024Cyanokit 5 g, powder for solution for infusion – [hydroxocobalamin]
    Supply voltageOct. 18, 2024Isocard, sublingual solution in spray bottle – [isosorbide dinitrate]
    Supply tensionOct. 18, 2024Paliperidone Teva, prolonged-release suspension for injection – [paliperidone]
    Supply tensionOct. 17, 2024Levodopa Carbidopa Teva 100 mg/10 mg, scored tablet – [levodopa – carbidopa]
    Supply tensionOct. 17, 2024Levodopa Carbidopa Teva 250 mg/25 mg, scored tablet – [levodopa – carbidopa]
    Out of stockOct. 17, 2024NovoEight 3000 IU powder and solvent for solution for injection – [turoctocog alfa] [turoctocog alfa] [turoctocog alfa] [turoctocog alfa
    AvailabilityOct. 16, 2024Solumedrol 120 mg/2 ml, lyophilisate and solution for parenteral use – [methylprednisolone (hydrogen succinate)]
    Supply tensionOct. 16, 2024Atropine 1%, eye drops – [atropine (sulfate)
    AvailabilityOct. 16, 2024Tofranil 25 mg, coated tablet – [Imipramine]
    Out of stockOct. 16, 2024Zophren 2 mg/ml, solution for injection in ampoule (IV), (box 1 ampoule of 4 ml) – [ondansetron].
    Remise à dispositionOct. 16, 2024Irinotecan Sun 1.5 mg/ml, solution for infusion – [irinotecan (hydrochloride) trihydrate]
    AvailabilityOct. 15, 2024Solumedrol 40 mg/1 mL, powder and solvent for solution for injection – [methylprednisolone hemisuccinate]
    Supply tensionOct. 15, 2024Ondansetron Viatris 2 mg/ml, solution for injection (I.V.) – [ondansetron]
    Supply tensionOct. 14, 2024Fluorescein Faure 0.5%, eye drops solution in single-dose container – [fluorescein sodium].
    AvailabilityOct. 11, 2024Nozinan 100 mg, scored film-coated tablet – [levomepromazine (maleate)]
    Supply tensionOct. 11, 2024Noyada 25 mg/5 ml, oral solution – [captopril]
    Out of stockOct. 11, 2024Yellox 0.9 mg/ml, eye drops solution – [bromfenac sodium sesquihydrate].
    Supply tensionOct. 11, 2024Praluent 75 mg, 150 mg and 300 mg, solution for injection in pre-filled pen – [alirocumab (mammalian/hamster/ cho cells)].
    AvailabilityOct. 10, 2024NovoEight 2000 IU powder and solvent for injectable solution – [turoctocog alfa]
  • 2024.10.10
    ステータス (英語)アップデートスペシャルティ
    回復2024年10月9日トリフルカン 40mg/ml、経口懸濁用粉末 – [フルコナゾール]
    回復2024年10月9日フレカイニド100mg、点滴静注用 – [フレカイニド(酢酸塩]
    回復2024年10月9日ノボセブン8mg(400KUI)、注射用粉末および溶液用溶剤-[エプタコグ アルファ(活性化)-(哺乳類/ハムスター/BHK細胞)]について
    在庫切れ2024年10月7日トキシカーブ 飲む懸濁液 【活性炭
    在庫切れ2024年10月7日メトトレキサート・アコード 100mg/mL、輸液用希釈液 – [メトトレキサート]
    供給の緊張2024年10月4日アトロピン1%点眼液 – [アトロピン(硫酸塩)
    回復2024年10月4日コアガデックス500IU、注射用溶液の粉末および溶媒 – [ヒト凝固第X因子]
    在庫切れ2024年10月3日パクリタキセルAHCL 6 mg/ml、輸液用希釈液 – 100 ml バイアル – [パクリタキセル]
    供給の緊張2024年10月3日トランキセン 20mg/2mL、凍結乾燥品および非経口用溶液 – [クロラゼプ酸ジカリウム]
    在庫切れ2024年10月3日エトポシド・アコード 20mg/ml、輸液用希釈液 – [エトポシド]
    供給の緊張2024年10月3日トルリシティ 0.75mg、1.5mg、3mg、4.5mg、プレフィルドペン注射液 – [デュラグルチド]
    供給の緊張2024年10月2日トランドラプリル0.5mg、カプセル – [trandolapril]
    供給の緊張2024年10月2日パリペリドン・テバ、注射用徐放性懸濁液 – [パリペリドン]
    供給の緊張2024年10月2日免疫グロブリン点滴静注用・静注用(ベース)-[免疫グロブリン点滴静注用(IgG)]。
    供給の緊張2024年10月1日タイエン162mg、プレフィルドペンおよびプレフィルドシリンジ入り注射液 – [トシリズマブ]
    回復2024年10月1日ジナート125mg/5ml小児・乳児用、経口懸濁用顆粒80ml入りボトル – [セフロキシム・アキセチル]
    供給の緊張2024年10月1日ロピニロールLP 2mg、4mg、8mg フィルムコーティング錠 – [ロピニロール(塩酸塩)
    供給の緊張2024年9月30日リネゾリド 2mg/ml、輸液用 – 【リネゾリド
    在庫切れ2024年9月30日トランドラプリル2mg、4mg – [trandolapril]

英国

EU

EUの情報はありません。

このページの先頭へ戻る